Microbot Medical Stock Alpha and Beta Analysis
| MBOT Stock | USD 0.97 0.02 2.02% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Microbot Medical. It also helps investors analyze the systematic and unsystematic risks associated with investing in Microbot Medical over a specified time horizon. Remember, high Microbot Medical's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Microbot Medical's market risk premium analysis include:
Beta 0.95 | Alpha (0.11) | Risk 2.98 | Sharpe Ratio 0.0663 | Expected Return 0.2 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Microbot |
Microbot Medical Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Microbot Medical market risk premium is the additional return an investor will receive from holding Microbot Medical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Microbot Medical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Microbot Medical's performance over market.| α | -0.11 | β | 0.95 |
Microbot Medical expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Microbot Medical's Buy-and-hold return. Our buy-and-hold chart shows how Microbot Medical performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Microbot Medical Market Price Analysis
Market price analysis indicators help investors to evaluate how Microbot Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Microbot Medical shares will generate the highest return on investment. By understating and applying Microbot Medical stock market price indicators, traders can identify Microbot Medical position entry and exit signals to maximize returns.
Microbot Medical Return and Market Media
The median price of Microbot Medical for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 is 0.94 with a coefficient of variation of 5.24. The daily time series for the period is distributed with a sample standard deviation of 0.05, arithmetic mean of 0.94, and mean deviation of 0.04. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Microbot Medical Announces the Successful Enrollment of 50 percent of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surg... | 09/17/2024 |
2 | Head-To-Head Analysis Microbot Medical SeaStar Medical | 10/14/2024 |
3 | Microbot Medical completes human clinical trial in its ACCESS-PVI | 10/15/2024 |
4 | Microbot Medical Releases Investor Presentation Materials - TipRanks | 10/31/2024 |
About Microbot Medical Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Microbot or other stocks. Alpha measures the amount that position in Microbot Medical has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Dividend Yield | 61.49 | 58.41 | Price To Sales Ratio | 383.31 | 302.36 |
Microbot Medical Upcoming Company Events
As portrayed in its financial statements, the presentation of Microbot Medical's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Microbot Medical's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Microbot Medical's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Microbot Medical. Please utilize our Beneish M Score to check the likelihood of Microbot Medical's management manipulating its earnings.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 15th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 29th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Microbot Medical
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Microbot Stock Analysis
When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.